HUT53115A - Process for production of alpha-glukozitade inhibitors and medical compositions containing them as active substance - Google Patents

Process for production of alpha-glukozitade inhibitors and medical compositions containing them as active substance

Info

Publication number
HUT53115A
HUT53115A HU901879A HU187990A HUT53115A HU T53115 A HUT53115 A HU T53115A HU 901879 A HU901879 A HU 901879A HU 187990 A HU187990 A HU 187990A HU T53115 A HUT53115 A HU T53115A
Authority
HU
Hungary
Prior art keywords
glukozitade
inhibitors
alpha
production
active substance
Prior art date
Application number
HU901879A
Other languages
English (en)
Other versions
HU901879D0 (en
Inventor
Jean-Bernard Ducep
Charles Danzin
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of HU901879D0 publication Critical patent/HU901879D0/hu
Publication of HUT53115A publication Critical patent/HUT53115A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
HU901879A 1989-03-29 1990-03-28 Process for production of alpha-glukozitade inhibitors and medical compositions containing them as active substance HUT53115A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89400881A EP0389723A1 (en) 1989-03-29 1989-03-29 Novel alpha-glucosidase inhibitors

Publications (2)

Publication Number Publication Date
HU901879D0 HU901879D0 (en) 1990-08-28
HUT53115A true HUT53115A (en) 1990-09-28

Family

ID=8202943

Family Applications (1)

Application Number Title Priority Date Filing Date
HU901879A HUT53115A (en) 1989-03-29 1990-03-28 Process for production of alpha-glukozitade inhibitors and medical compositions containing them as active substance

Country Status (10)

Country Link
EP (2) EP0389723A1 (hu)
JP (1) JPH02268154A (hu)
CN (1) CN1045975A (hu)
AU (1) AU5217990A (hu)
CA (1) CA2013382A1 (hu)
FI (1) FI901548A0 (hu)
HU (1) HUT53115A (hu)
NO (1) NO901422L (hu)
PT (1) PT93590A (hu)
ZA (1) ZA902279B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844102A (en) * 1994-07-07 1998-12-01 University Of Maryland Baltimore County Glycohydrolase inhibitors, their preparation and use thereof
JP3043430B2 (ja) * 1995-09-08 2000-05-22 ノボ ノルディスク アクティーゼルスカブ ２−アルキルピロリジン類
US6455573B1 (en) * 2000-01-07 2002-09-24 Simon Fraser University Glycosidase inhibitors and methods of synthesizing same
CN114249718B (zh) * 2021-10-28 2023-09-22 中国药科大学 锍鎓盐类衍生物及其制备方法和医药用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS60193997A (ja) * 1984-03-14 1985-10-02 Sumitomo Chem Co Ltd 新規シアノイミダゾ−ルリボヌクレオシド誘導体およびその製造法
US4681873A (en) * 1985-07-29 1987-07-21 Warner-Lambert Company 4-amino-3-halo-2-pyridinone nucleoside and nucleotide compounds
EP0345104B1 (en) * 1988-06-02 1995-11-02 Merrell Dow Pharmaceuticals Inc. Novel Alpha-glucosidase inhibitors

Also Published As

Publication number Publication date
FI901548A0 (fi) 1990-03-28
JPH02268154A (ja) 1990-11-01
EP0389723A1 (en) 1990-10-03
AU5217990A (en) 1990-10-04
NO901422L (no) 1990-10-01
EP0390674A1 (en) 1990-10-03
PT93590A (pt) 1990-11-20
HU901879D0 (en) 1990-08-28
CA2013382A1 (en) 1990-09-29
CN1045975A (zh) 1990-10-10
NO901422D0 (no) 1990-03-28
ZA902279B (en) 1990-12-28

Similar Documents

Publication Publication Date Title
HUT50152A (en) Process for production of derivatives of benzopiran and medical compositions containing them as active substance
HUT47576A (en) Process for production of 2-amin-purin-derivatives and medical compositions containing them as active substance
HUT51862A (en) Insecticides containing as active substance nitrocompositions and process for production of these compositions
HUT42479A (en) Process for production of derivatives of quinasoline and medical preparatives containing thereof as active substance
HUT50190A (en) Process for production of n-substituated 1-dezoxinogimiricin and 1-dezoxi-manno-nogimiricin and medical compositions containing them
HUT47596A (en) Process for production of derivatives of amin acid and medical compositions containing them as active substance
HUT51279A (en) Process for producing 2-phosphate-esters of ascorbinic acid and pharmaceutical compositions containing them as active components
HUT44489A (en) Process for production of derivatives of benzosulphonamid-indanyl and medical preparatives containing them as active substance
HUT43837A (en) Process for production of n-benzhydril-diazacycloalkylalcane-anilides and medical compounds containing thereof as active substance
HUT47592A (en) Process for production of derivatives of dideoxicitidin and medical compositions containg them as active substance
HUT49147A (en) Process for production of derivatives of amin acid and medical compositions containg them as active substance
HUT48581A (en) Process for production of derivatives of substituated pirrol and medical preparatives containing them as active substance
HUT49149A (en) Process for production of derivatives of amin acid and medical compositions containing them as active substance
HUT46900A (en) Process for production of derivatives of 7-/acyl-oxi/-6-/amin-axyl-oxi/-polioxi-labdane and medical compounds containing them as active substance
HUT51247A (en) Process for production of aryl-zyanguananidins and medical compositions containing them
HUT50194A (en) Process for production of new derivatives of neplanocine and medical compositions containing them as active substance
HUT46888A (en) Process for production of 2-acyl-pirrolidin-derivatives and medical preparatives containing such compounds as active substances
HUT40098A (en) Process for production of halogen-hidroxi-flavons and medical preparatives containing thereof as active substance
HUT47267A (en) Process for production of new pirasoline-derivatives and medical compositions containing them
HUT50167A (en) Process for production of derivatives of tetrasole and medical compositions containing them
HUT51284A (en) Process for production of epipodofillotoxin glucozides substituated by fluor and medical compositions containing them as active substance
HUT50196A (en) Process for production of neuroquinine a antagonists and medical compositions containing them as active substance
HUT45268A (en) Process for production of tripeptide-agregations and medical preparatives containing them as active substance
HUT50762A (en) Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance
HUT49807A (en) Process for production of medical compositions and the active substance

Legal Events

Date Code Title Description
DFC9 Refusal of application